HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 368 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,344 | +5.3% | 113,720 | -0.5% | 0.01% | +11.1% |
| Q2 2023 | $4,124 | -6.7% | 114,320 | -1.2% | 0.01% | -10.0% |
| Q1 2023 | $4,418 | -33.6% | 115,681 | -1.1% | 0.01% | -37.5% |
| Q4 2022 | $6,652 | -99.9% | 116,914 | +0.2% | 0.02% | +33.3% |
| Q3 2022 | $4,616,000 | -10.6% | 116,736 | -0.5% | 0.01% | -7.7% |
| Q2 2022 | $5,162,000 | +14.1% | 117,323 | +3.4% | 0.01% | +44.4% |
| Q1 2022 | $4,526,000 | -0.6% | 113,486 | +0.2% | 0.01% | 0.0% |
| Q4 2021 | $4,555,000 | +15.8% | 113,286 | +17.1% | 0.01% | +12.5% |
| Q3 2021 | $3,935,000 | -0.6% | 96,728 | +10.9% | 0.01% | 0.0% |
| Q2 2021 | $3,960,000 | +13.7% | 87,211 | +4.4% | 0.01% | +14.3% |
| Q1 2021 | $3,483,000 | +2237.6% | 83,553 | +2287.2% | 0.01% | – |
| Q4 2020 | $149,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |